- testing |
| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 28 Oct 2025 | 17 Oct 2025 |
| Newgen Software Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2025 inter alia to consider and approve Enclosed Board Meeting Intimation Enclosed Board Meeting Outcome (As per BSE Announcement dated on: 28.10.2025) | ||
| Board Meeting | 17 Jul 2025 | 11 Jul 2025 |
| Quarterly Results Newgen Software Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/07/2025 ,inter alia, to consider and approve Newgen Software Technologies Limited has informed the Exchange about Board meeting to be held on 17-July-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the 1st Quarter ended 30th June 2025 (As per BSE Announcement Dated on 11/07/2025) Enclosed Outcome of Board Meeting (As Per BSE Announcement Dated on: 17/07/2025) | ||
| Board Meeting | 2 May 2025 | 24 Apr 2025 |
| Newgen Software Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2025 inter alia to consider and approve 1. Audited Standalone and Consolidated Financial Results. 2.Recommend Dividend for the financial year 2024-2025. Enclosed Outcome of Board Meeting Recommended a final dividend of Rs. 5/- (five) per equity share (on face value of Rs. 10/- each) i.e. 50% on a face value of Rs. 10/- per share, for the year ended 31st March 2025 subject to the approval of the Shareholders at the forthcoming Annual General Meeting. (As Per BSE Announcement Dated on 02.05.2025) | ||
| Board Meeting | 20 Jan 2025 | 13 Jan 2025 |
| Newgen Software Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/01/2025 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the 3rd Quarter Ended 31st December 2024 Approved the Unaudited Standalone and Consolidated for the quarter and nine months ended 31st December 2024 This is to inform you that the Board of Directors of the Company at its meeting held today i.e. Monday, 20th January 2025 which commenced at 12:40 P.M. and concluded at 01:10 P.M. On the basis of recommendation of Nomination & Remuneration Committee, the Board approved grant of 73050 options under Newgen ESOP Scheme-2022. This is to inform that the Board of Directors in its meeting held today alloted shares under Newgen ESOP Scheme-2022 and Newgen RSU 2021 Scheme. (As per BSE Announcement Dated on 20/01/2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.